Maternal Variables Associated With Adherence in Children With Asthma (asthma)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Information provided by:
Hadassah Medical Organization Identifier:
First received: May 29, 2008
Last updated: June 2, 2008
Last verified: May 2008
A questionnaire will be used in order to find out the reasons for poor adherence for long-term treatment in children with asthma. The hypotheses is maternal factors including the knowledge that asthma is a chronic disease and fear to administer inhaled steroids are major obstacles for appropriate adherence.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Reasons for Poor Adherence for Long-Term Preventing Therapy in Children With Asthma

Resource links provided by NLM:

Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 100
Study Start Date: July 2008
Estimated Study Completion Date: June 2011
Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Detailed Description:
Parents to children aged 2 - 12 years with moderate to severe asthma who need long-term treatment with inhaled steroids will be included in the study. Three weeks after their visit in the clinic, they will be requested to answer a questionnaire by telephone.

Ages Eligible for Study:   2 Years to 12 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Parents to children aged 2 - 12 years with moderate to severe asthma.

Inclusion Criteria:

  • Parents to children aged 2 - 12 years with moderate to severe asthma to whom inhaled steroids was described for a period of at least 4 weeks.

Exclusion Criteria:

  • Parents who will not agree to sign the consent form and parents who do not speak and understand the Hebrew language.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00688792

Contact: Dan Engelhard, MD 972-2-677-8960

Hadassah Medical Organization Not yet recruiting
Jerusalem, Israel, 91120
Contact: Arik Tzukert, DMD    972-2-677-6095   
Contact: Hadas Lemberg, PhD    972-2-677-7572   
Principal Investigator: Dan Engelhard, MD         
Sponsors and Collaborators
Hadassah Medical Organization
Principal Investigator: Dan Engelhard, MD Hadassah Medical Organization
  More Information

No publications provided

Responsible Party: Prof. Dan Engelhard, MD, Hadassah Medical Organization Identifier: NCT00688792     History of Changes
Other Study ID Numbers: asthma1-HMO-CTIL
Study First Received: May 29, 2008
Last Updated: June 2, 2008
Health Authority: Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:
Maternal factors

Additional relevant MeSH terms:
Bronchial Diseases
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases processed this record on November 25, 2015